GlaxoSmithKline receives antitrust penalty: the agreement to delay the entry of generic drugs is illegal
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
You May Interested In
2026-08-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?
-
Breakthrough Collaboration: Johnson Pharmaceuticals and GSK Join Forces to Advance ADC Therapy HS-20093
-
GlaxoSmithKline Acquires Exclusive Licensing Rights for Johnson Pharmaceuticals' Promising ADC Drug HS-20089: A Potential Breakthrough Therapy for Gynecologic Cancers
-
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demand for Vaccines
-
3 billion, nearly 10 years, why GlaxoSmithKline again?
-
A large number of pharmaceutical companies are in trouble
-
GlaxoSmithKline HPV Vaccine Two-dose Schedule Approved in China
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
European EMA Removes About 100 Generic Drugs Involving Johnson & Johnson, Sandoz, Teva, etc.
-
Global Biologicals M&A Storm: How 2025 Redrew the Agricultural Innovation Map
Recommend Reading
-
![He Spent 40 Years at Nestlé—Then Was “Cleared Out” Days After Becoming CEO: This Isn’t a Scandal, It’s Capital’s Coldest Face]()
He Spent 40 Years at Nestlé—Then Was “Cleared Out” Days After Becoming CEO: This Isn’t a Scandal, It’s Capital’s Coldest Face
-
![Australia Approves Lab-Grown “Milk Sugar” for Babies—A Breakthrough in Infant Nutrition]()
Australia Approves Lab-Grown “Milk Sugar” for Babies—A Breakthrough in Infant Nutrition
-
![Geno and Sojitz Collaborate to Accelerate the Commercialization of Nylon 6]()
Geno and Sojitz Collaborate to Accelerate the Commercialization of Nylon 6
-
![BASF's Zhanjiang Integrated Site Reaches Major Milestone: Butyl Acrylate Production Commences Ahead of Schedule, Steam Cracker Completes Mechanical Completion]()
BASF's Zhanjiang Integrated Site Reaches Major Milestone: Butyl Acrylate Production Commences Ahead of Schedule, Steam Cracker Completes Mechanical Completion
-
![From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use]()
From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use
-
![This week, the Aniline market in China showed a strong increase (1.5-1.9)]()
This week, the Aniline market in China showed a strong increase (1.5-1.9)
-
![May China Gasoline and Diesel Market Trends Show Volatility]()
May China Gasoline and Diesel Market Trends Show Volatility
-
![This Week's Activated Carbon Prices Rise in China (1.5-1.9)]()
This Week's Activated Carbon Prices Rise in China (1.5-1.9)
-
![This week, China's 180CST fuel oil market trend is downward]()
This week, China's 180CST fuel oil market trend is downward
-
![Positive Factors Drive Up Butanol Market]()
Positive Factors Drive Up Butanol Market
